Literature DB >> 19609013

WWOX, the tumour suppressor gene affected in multiple cancers.

U Lewandowska1, M Zelazowski, K Seta, M Byczewska, E Pluciennik, A K Bednarek.   

Abstract

WWOX is a tumour suppressor gene affected in multiple cancers, especially in breast, prostate and ovary. This gene is located at the chromosomal area 16q23.3-24.1, which was identified as a common chromosomal fragile site FRA16D. WWOX turned out to possess tumour suppressor features despite the fact that the most basic (classical) way of tumour suppressor gene inactivation involves both alleles (e.g. through deletions, point mutations and promoter methylation), which is very rare event in a case of WWOX, occurring only in few cell lines. A large number of papers corroborate the phenomenon of correlation between the loss of WWOX expression and more aggressive/worse prognosis in many different types of tumours, for example breast cancer, nonsmall cell lung cancer, bladder cancer, gastric cancer or sporadic meningiomas. Ectopically increased WWOX expression promotes migration through basal membrane, however suppresses anchorage independent growth and induces normal-like colony formation in matrigel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19609013

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  32 in total

1.  Genomic rearrangements at the FRA2H common fragile site frequently involve non-homologous recombination events across LTR and L1(LINE) repeats.

Authors:  Lena M Brueckner; Evgeny Sagulenko; Elisa M Hess; Diana Zheglo; Anne Blumrich; Manfred Schwab; Larissa Savelyeva
Journal:  Hum Genet       Date:  2012-04-05       Impact factor: 4.132

Review 2.  Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.

Authors:  Amjad Farooq
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-07

3.  Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma.

Authors:  Sara Del Mare; Kyle C Kurek; Gary S Stein; Jane B Lian; Rami I Aqeilan
Journal:  Am J Cancer Res       Date:  2011-04-03       Impact factor: 6.166

4.  Adenovirus-delivered wwox inhibited lung cancer growth in vivo in a mouse model.

Authors:  Y Zhou; F Shou; H Zhang; Q You
Journal:  Cancer Gene Ther       Date:  2015-10-30       Impact factor: 5.987

5.  Genetic alterations of the WWOX gene in breast cancer.

Authors:  Seda Ekizoglu; Mahmut Muslumanoglu; Nejat Dalay; Nur Buyru
Journal:  Med Oncol       Date:  2011-10-08       Impact factor: 3.064

Review 6.  WWOX gene and gene product: tumor suppression through specific protein interactions.

Authors:  Zaidoun Salah; Rami Aqeilan; Kay Huebner
Journal:  Future Oncol       Date:  2010-02       Impact factor: 3.404

Review 7.  Molecular characterization of common fragile sites as a strategy to discover cancer susceptibility genes.

Authors:  Larissa Savelyeva; Lena M Brueckner
Journal:  Cell Mol Life Sci       Date:  2014-09-18       Impact factor: 9.261

8.  Exploring the mechanism of WWOX growth inhibitory effects on oral squamous cell carcinoma.

Authors:  Wei Yang; Xiao-Ming Wang; Hong-Yan Yuan; Zhi-Hui Liu; Shuang Gao; Liang Peng
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

9.  Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material.

Authors:  Alessandro Laganà; Francesco Russo; Catarina Sismeiro; Rosalba Giugno; Alfredo Pulvirenti; Alfredo Ferro
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

10.  Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme.

Authors:  Katarzyna Kosla; Elzbieta Pluciennik; Agata Kurzyk; Dorota Jesionek-Kupnicka; Radzislaw Kordek; Piotr Potemski; Andrzej K Bednarek
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.